November 15, 2013
Which would you choose if you were diagnosed with early-stage breast cancer? You could receive a standard chemo regimen, followed three months later by an MRI scan to determine the treatment's success. Or, instead, a genomic analysis of your biopsied breast tissue could help determine a drug regimen tailored to your own genetic makeup.
November 15, 2013
If biology is destiny, then the slightest change in a gene's DNA can become an agent of destiny.
November 14, 2013
With inexpensive genetics kits flooding the market, both consumers – and their doctors – still lack basic information about what to do, if anything, with what they learn about their own genomes.
November 11, 2013
UC San Francisco scientists report that they were able to arrest, and even reverse, tissue scarring of the liver, kidneys and lungs in mice.
November 7, 2013
It might seem obvious that humans are elegant and sophisticated beings in comparison to lowly bacteria. But when it comes to genes, a UC San Francisco scientist wants to turn conventional wisdom about human and bacterial evolution on its head.
October 21, 2013
Three UC San Francisco faculty members are among the 70 newly elected members of the Institute of Medicine (IOM), considered one of the highest honors in the health sciences.
October 16, 2013
A UC San Francisco-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
October 14, 2013
The annual prostate cancer research retreat provided a lively sampling of the work of many UCSF investigators focused on this disease.
October 11, 2013
The way cells divide to form new cells — to support growth, to repair damaged tissues, or simply to maintain our healthy adult functioning — is controlled in previously unsuspected ways UC San Francisco researchers have discovered. The findings, they said, may lead to new ways to fight cancer.
October 3, 2013
Often deadly "triple-negative" breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, according to a new UC San Francisco study.